Health Care M&A Deals, October 23, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is H.I.G. Capital’s acquisition of St. Croix Hospice for $580 million from The Vistria Group. St. Croix Hospice is a leading provider of hospice care across the Midwestern United States, serving an area that covers six contiguous states. It recently purchased Serenity Care Hospice in Missouri and Hometown Hospice & Homecare in Wisconsin.... Read More »
Health Care M&A Deals, October 16, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is WellSky’s acquisition of CarePort Health for $1.35 billion. CarePort Health is an end-to-end post-acute care coordination platform that bridges acute and post-acute EHR data. Allscripts is selling CarePort in this deal. With this transaction, WellSky is positioned to manage the acute care discharge process, track patients across post-acute... Read More »
Health Care M&A Deals, October 9, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Bristol Myers Squibb’s $13.1 billion takeover of MyoKardia, Inc., a clinical-stage biopharmaceutical company discovering and developing targeted therapies for the treatment of serious cardiovascular diseases. Bristol Myers Squibb will gain mavacamten, a potential first-in-class cardiovascular medicine for the treatment of obstructive... Read More »
Healthcare M&A Activity in Third Quarter Leveled Out
Things felt tough in the third quarter. According to the Centers for Disease Control, the United States passed 7 million cases of COVID-19, with over 200,000 confirmed deaths, or 20% of the deaths caused by the pandemic worldwide. The 2020 presidential election kicked into full swing, but no one seems thrilled by reports coming out of the race. The healthcare M&A market, however, showed promise. According to results in our HealthCareMandA.com Deal Database, deal volume in Q3:20 remained flat compared with Q2:20; stabilization is a welcome change after months of decline. In Q3:20, there were 342 transactions announced, compared with 341 deals in Q2:20 and 461 in Q3:19. Source:... Read More »
Health Care M&A Deals, October 2, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AEW Capital Management’s purchase of a Welltower (NYSE: WELL) portfolio consisting of 10 seniors housing communities and 1,507 units located in California, Nevada and Washington. They were primarily independent living communities, with assisted living, memory care and multifamily units too. The purchase price was just over $700 million. To... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
